EUVIMEDEUVIMED entdecken
Crossref

Ultrasensitive single-particle collision electrochemical platform employing CRISPR/Cas12a for ctDNA biosensing

Siwei Shi, Fuxing Qin, Jiaxuan Wu, Jinshan Yang, Xiuhua Zhang, Shengfu Wang, Wei Wen, Zhen Wu

Analytica Chimica Acta · 2025

DOI: 10.1016/j.aca.2025.344590 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2025. Verfasst von Siwei Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory for Precision Synthesis of Small Molecule Pharmaceuticals & Ministry of Education Key Laboratory for the Synthesis and Applicati…. Hauptthemen laut MEDLINE: Electrochemical Techniques, Circulating Tumor DNA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Hubei Province Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circulating tumor DNA (ctDNA) is a characteristic tumor biomarker used for cancer diagnosis, treatment, and prognosis. However, the low concentration of ctDNA in peripheral blood and the interference of complex matrices with signals make the detection of ctDNA extremely challenging. Single-particle collision electrochemistry (SPCE) has been widely used in bioanalysis due to its advantages such as high throughput, simple operation, high sensitivity, and low detection limit. In this work, a novel SPCE biosensor for the rapid detection of ctDNA was developed by combining CRISPR/Cas12a with excellent cleavage activity and magnetic beads (MBs) with good separation and enrichment capabilities. The trans-cleavage ability of CRISPR/Cas12a can only be triggered in the presence of target ctDNA to effectively cleave the ssDNA2 on the surface of Ag NPs-ssDNA2 within 1 h, thereby activating the collision activity of silver nanoparticles (Ag NPs). ctDNA was quantified by the collision frequency of Ag NPs. The detection limit of the developed SPCE biosensor for ctDNA was as low as 4.2 fM, and the linear range was 10 fM-1 nM. In addition, MBs allow the biosensor to detect ctDNA in complex samples by directly sampling from complex matrices, with excellent sensitivity and specificity, demonstrating the great potential of the developed SPCE biosensor in the detection of patient samples.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Electrochemical TechniquesCirculating Tumor DNACRISPR-Cas SystemsBiosensing TechniquesLimit of DetectionSilverMetal NanoparticlesHumans

Stichwörter der Autor:innen

Ag NPsCRISPR/Cas12aCirculating tumor DNASingle-particle collision electrochemistry

Substanzen

Circulating Tumor DNASilver

Autor:innen und Institutionen

  • Hubei Key Laboratory for Precision Synthesis of Small Molecule Pharmaceuticals & Ministry of Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules & College of Chemistry and Chemical…

Förderung

  • Hubei Province Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Shi, S., Qin, F., Wu, J., Yang, J., Zhang, X., Wang, S., Wen, W., & Wu, Z. (2025). Ultrasensitive single-particle collision electrochemical platform employing CRISPR/Cas12a for ctDNA biosensing. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2025.344590

Vancouver

Shi S, Qin F, Wu J, Yang J, Zhang X, Wang S, et al. Ultrasensitive single-particle collision electrochemical platform employing CRISPR/Cas12a for ctDNA biosensing. Analytica Chimica Acta. 2025. doi:10.1016/j.aca.2025.344590

BibTeX
@article{Shi2025,
  author = {Shi, Siwei and Qin, Fuxing and Wu, Jiaxuan and Yang, Jinshan and Zhang, Xiuhua and Wang, Shengfu and Wen, Wei and Wu, Zhen},
  title = {Ultrasensitive single-particle collision electrochemical platform employing CRISPR/Cas12a for ctDNA biosensing},
  journal = {Analytica Chimica Acta},
  year = {2025},
  doi = {10.1016/j.aca.2025.344590}
}
Kostenlos starten →